Illusions of objectivity and a recommendation for reporting data mining results

European Journal of Clinical Pharmacology

Volumn 63, Issue 5, 2007, Pages 517-521

  Hauben, Manfred ^a,b,c,d   Reich, Lester ^a   Gerrits, Charles M ^e   Younus, Muhammad ^f  

^a PFIZER INC   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d BRUNEL UNIVERSITY   (United Kingdom)

^e TAKEDA PHARMACEUTICALS   (United States)

^f MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Adverse drug reaction reporting systems; Association measures; Pharmacovigilance; Post marketing surveillance

Indexed keywords

ARTICLE; COMPUTER PROGRAM; DATA ANALYSIS SOFTWARE; DATA BASE; DATA MINING; INFORMATION PROCESSING; PRIORITY JOURNAL;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; COMMERCE; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; HUMANS; PHARMACEUTICAL PREPARATIONS; PRODUCT SURVEILLANCE, POSTMARKETING; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SOFTWARE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 34147138368     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0279-3     Document Type: Article

References (15)

1. Szarfman A, Machado SG, O'Neill RT (2002) Use of screening algorithms and computer systems to efficiently signal higher-thanexpected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf 25(6):381-392
2. Hauben M, Patadia VK, Gerrits CM, Walsh L, Reich L (2005) Data mining in pharmacovigilance: the need for a balanced perspective. Drug Saf 28(10):835-842
3. Hauben M, Patadia VK, Goldsmith D (2006) What Counts in Data Mining? Drug Saf 29(10):827-832
4. Solomon R, Dumouchel W (2006) Contrast media and nephropathy: findings from systematic analysis and food and drug administration reports of adverse effects. Invest Radiol 41 (8):651-660
5. Hauben M, Van Puijenbroek EP, Gerrits CM, Patadia VK (2006) Data mining in pharmacovigilance: lessons from phantom ships. Eur J Clin Pharmacol 62:967-970
6. Evans SJ, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10 (6):483-486
7. Thomson Diogenes Adverse Drug Event Database File 181. Available at http://www.dialog.com by subscription (Accessed July 2006)
8. Roux E, Frantz T, Fourrier, Begaud B, Tubert-Bitter P (2005) Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance. IEEE Trans Inf Technol Biomed 9(4):518-27
9. Hauben M, Reich L, Gabbay F (2006) Extension of points on clarifying terminology in drug safety. Drug Saf 29(3):273-275
10. Hauben M, Reich L (2005) Endotoxin-like reactions with intravenous gentamicin: results from pharmacovigilance tools under investigation. Infect Control Hosp Epidemiol 26(4):391-394
11. Hauben M, Reich L, Chung S (2004) Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms. Eur J Clin Pharmacol 60 (10):747-750
12. Hauben M, Reich L (2004) Data mining, drug safety, and molecular pharmacology: potential for collaboration. Ann Pharmacother 38 (12):2174-2175
13. Hand DJ (2006) Rejoinder: classifier technology and the illusion of progress. Statistical Science 21(1):1-15
14. Friedman JH (2006) Comment: classifier technology and the illusion of progress. Statistical Science 21(1):15-18
15. Bate A, Edwards IR (2006) Data mining in spontaneous reports. Basic Clin Pharmacol Toxicol 98(3):324-330